Get the Stockscreener App
0.58
3.33%
-0.02
Sol Gel Technologies Ltd stock is traded at $0.58, with a volume of 21,959.
It is down -3.33% in the last 24 hours and down -35.44% over the past month.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.
See More
Previous Close:
$0.60
Open:
$0.57
24h Volume:
21,959
Relative Volume:
0.05
Market Cap:
$16.16M
Revenue:
$6.56M
Net Income/Loss:
$-14.92M
P/E Ratio:
-1.0741
EPS:
-0.54
Net Cash Flow:
$-33.87M
1W Performance:
-4.92%
1M Performance:
-35.44%
6M Performance:
-3.33%
1Y Performance:
-47.75%
1-Day Range:
$0.57
$0.5999
1-Week Range:
$0.5606
$0.634
52-Week Range:
$0.334
$1.65
Sol Gel Technologies Ltd Stock (SLGL) Company Profile
Name
Sol Gel Technologies Ltd
Sector
Industry
Phone
-
Address
-
Compare SLGL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLGL
Sol Gel Technologies Ltd
|
0.58 | 16.16M | 6.56M | -14.92M | -33.87M | -0.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-21-22 | Resumed | Jefferies | Hold |
| Dec-31-19 | Reiterated | H.C. Wainwright | Buy |
| Dec-31-19 | Reiterated | JMP Securities | Mkt Outperform |
Sol Gel Technologies Ltd Stock (SLGL) Latest News
Sol-Gel Technologies Schedules Shareholder Meeting to Vote on Key Proposals - TipRanks
Basal Cell Nevus Syndrome Treatment Market Size in the 7MM - openPR
Biotech Stocks Facing FDA Decision In August 2021 - RTTNews
Sol-Gel Technologies Ltd (SLGL) Shares Decline Despite Market Challenges - The News Heater
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Not Doing Enough For Some Investors As Its Shares Slump 51% - Simply Wall St
Is Sol-Gel Technologies (NASDAQ:SLGL) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Constellium SE’s (CSTM) Stock: A -3.86% Simple Moving Average for the Past 20 Days - The News Heater
Tronox Holdings plc (TROX): A Technical Analysis - The News Heater
PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson's Disease - Yahoo Finance
Rosacea Clinical Trials Analysis 2025: EMA, PDMA, FDA - openPR
Appointment of Dr. Bryan Jones as an Advisor to Lead Sol-Gel Special Projects - Yahoo Finance
Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews
Acne Vulgaris Market Size to Reach USD 10.4 Billion by 2035, with a Growth Rate (CAGR) of 3.33% during 2025-2035 - BioSpace
Rosacea Pipeline Analysis, Clinical Trials, EMA, PDMA, FDA - openPR
Actinic Keratosis Treatment Market 2034: EMA, PDMA, FDA Approvals, Prevalence, Clinical Trials, Medication, Therapies, and Companies by DelveInsight - The Globe and Mail
Acne Vulgaris Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, MOA, ROA by DelveInsight | Dermata Therapeutics, AstraZeneca, Novartis, UCB Pharma, Incyte Inc., Galderma - The Globe and Mail
Pre-market Movers: AVGR, TIVC, ATNF, SLGL... - RTTNews
DFD-29: The Journey to FDA Approval and a New Era in Rosacea Management - Dermatology Times
Acne Vulgaris Market Expected to Experience Major Growth by 2034, According to DelveInsight - EIN News
Pre-market Movers: SANA, SLDB, JSPR, DRIO... - RTTNews
Pre-market Movers: CDT, NARI, GDTC, NARI... - RTTNews
Is SolGel Technologies (SLGL) a Great Value Stock Right Now? - Yahoo Finance
There's Reason For Concern Over Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Massive 209% Price Jump - Simply Wall St
Why Carbon Revolution Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket - Benzinga
US Stocks Gain, Nasdaq Surges Over 100 PointsCheck-Cap (NASDAQ:CHEK), Baosheng Media Gr (NASDAQ:BAOS) - Benzinga
United States shares higher at close of trade; Dow Jones Industrial Average up 0.16% - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.16% - Investing.com
SLGL Stock Touches 52-Week High at $1.65 Amid Market Fluctuations - Investing.com
The Next-Generation Solar Cell Market Set to Reach $12.91 Billion by 2031. - openPR
Rosacea Treatment Market Growth in Future Scope 2024-2031 | - openPR
Solar Lighting System Market Trends and Future Opportunities 2024-2032 - openPR
Acne Vulgaris Pipeline Therapeutics Assessment Report 2024 (Updated) - openPR
Global Solar Street Lighting Market to Reach USD 12.38 Billion by 2029, Growing at a CAGR of 14.5% - openPR
Revolutionary Solar Lighting Innovations for 2024 - openPR
Sol-Gel Technologies Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Sol-Gel receives Nasdaq compliance extension By Investing.com - Investing.com Nigeria
Sol-Gel Technologies Reports Strong Q3 2024 Results - TipRanks
SolGel Technologies (SLGL) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Sol-Gel receives Nasdaq compliance extension - Investing.com India
SEALSQ updates on minimum bid price non-compliance - MSN
Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement - The Manila Times
Microlise Group Reassures Investors After Cyber Incident - MSN
Solar Lighting System Market Current Status and Future Prospects till 2031 - openPR
Smudge-Free Innovations: 2024 Global Market Insights on Anti-Fingerprint Coatings In The Latest Report - WhaTech
GlobalData Executes Share Buyback Program - MSN
Sol Gel Tech earnings beat by $0.04, revenue topped estimates - Investing.com South Africa
Sol-Gel Technologies Ltd. (SLGL) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Form 424B3 Sol-Gel Technologies - StreetInsider.com
SEC Form 424B3 filed by Sol-Gel Technologies Ltd. - Quantisnow
Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - The Manila Times
Sol-Gel Technologies Q3 Revenue Surges to $5.4M, Narrows Losses Amid Strategic Growth | SLGL Stock News - StockTitan
Sol Gel Technologies Ltd Stock (SLGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):